35
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Breast cancer is estimated to be the most common cancer worldwide. We sought to assemble publicly available data from Africa to provide estimates of the incidence of breast cancer on the continent.

          Methods

          A systematic search of Medline, EMBASE, Global Health and African Journals Online (AJOL) was conducted. We included population- or hospital-based registry studies on breast cancer conducted in Africa, and providing estimates of the crude incidence of breast cancer among women. A random effects meta-analysis was employed to determine the pooled incidence of breast cancer across studies.

          Results

          The literature search returned 4648 records, with 41 studies conducted across 54 study sites in 22 African countries selected. We observed important variations in reported cancer incidence between population- and hospital-based cancer registries. The overall pooled crude incidence of breast cancer from population-based registries was 24.5 per 100 000 person years (95% confidence interval (CI) 20.1-28.9). The incidence in North Africa was higher at 29.3 per 100 000 (95% CI 20.0-38.7) than Sub-Saharan Africa (SSA) at 22.4 per 100 000 (95% CI 17.2-28.0). In hospital-based registries, the overall pooled crude incidence rate was estimated at 23.6 per 100 000 (95% CI 18.5-28.7). SSA and Northern Africa had relatively comparable rates at 24.0 per 100 000 (95% CI 17.5-30.4) and 23.2 per 100 000 (95% CI 6.6-39.7), respectively. Across both registries, incidence rates increased considerably between 2000 and 2015.

          Conclusions

          The available evidence suggests a growing incidence of breast cancer in Africa. The representativeness of these estimates is uncertain due to the paucity of data in several countries and calendar years, as well as inconsistency in data collation and quality across existing cancer registries.

          Related collections

          Most cited references60

          • Record: found
          • Abstract: found
          • Article: not found

          Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration.

          Cancer Incidence in Five Continents (CI5), a longstanding collaboration between the International Agency for Research on Cancer and the International Association of Cancer Registries, serves as a unique source of cancer incidence data from high-quality population-based cancer registries around the world. The recent publication of Volume X comprises cancer incidence data from 290 registries covering 424 populations in 68 countries for the registration period 2003-2007. In this article, we assess the status of population-based cancer registries worldwide, describe the techniques used in CI5 to evaluate their quality and highlight the notable variation in the incidence rates of selected cancers contained within Volume X of CI5. We also discuss the Global Initiative for Cancer Registry Development as an international partnership that aims to reduce the disparities in availability of cancer incidence data for cancer control action, particularly in economically transitioning countries, already experiencing a rapid rise in the number of cancer patients annually.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The global breast cancer burden: variations in epidemiology and survival.

            Breast cancer is the most common type of cancer and the most common cause of cancer-related mortality among women worldwide. However, the burden is not evenly distributed, and, according to the best available data, there are large variations in the incidence, mortality, and survival between different countries and regions and within specific regions. Many complex factors underlie these variations, including population structure (eg, age, race, and ethnicity), lifestyle, environment, socioeconomic status, risk factor prevalence, mammography use, disease stage at diagnosis, and access to high-quality care. We review recent breast cancer incidence and mortality statistics and explore why these vary so greatly across the world. Further research is needed to fully understand the reasons for variations in breast cancer outcomes. This will aid the development of tailored strategies to improve outcomes in general as well as the standard of care for underserved populations and reduce the burden of breast cancer worldwide.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.

              Compared with white women, black women experience a disproportionate burden of aggressive breast cancer for reasons that remain unknown and understudied. In the first study of its kind, we determined the distribution of molecular subtypes of invasive breast tumors in indigenous black women in West Africa. The study comprised 507 patients diagnosed with breast cancer between 1996 and 2007 at six geographic regions in Nigeria and Senegal. Formalin-fixed and paraffin-embedded sections were constructed into tissue microarrays and immunostained with 15 antibodies. Five molecular subtypes were determined, and hierarchical cluster analysis was conducted to explore subgroups for unclassified cases. The mean (+/- standard deviation) age of 378 patients in the first cohort was 44.8 +/- 11.8 years, with the majority of women presenting with large (4.4 +/- 2.0 cm) high-grade tumors (83%) in advanced stages (72% node positive). The proportions of estrogen receptor (ER) -positive, progesterone receptor-positive, and human epidermal growth factor receptor 2 (HER2) -positive tumors were 24%, 20%, and 17%, respectively. Triple negativity for these markers was predominant, including basal-like (27%) and unclassified subtype (28%). Other subtypes were luminal A (27%), luminal B (2%), and HER2 positive/ER negative (15%). The findings were replicated in the second cohort of 129 patients. The unclassified cases could be grouped into a bad prognosis branch, with expression of vascular endothelial growth factor, B-cell lymphoma extra-large protein, and Cyclin E, and a good prognosis branch, with expression of B-cell lymphoma protein 2 and Cyclin D1. These findings underscore the urgent need for research into the etiology and treatment of the aggressive molecular subtypes that disproportionately affect young women in the African diaspora.
                Bookmark

                Author and article information

                Journal
                J Glob Health
                J Glob Health
                JGH
                Journal of Global Health
                Edinburgh University Global Health Society
                2047-2978
                2047-2986
                June 2018
                16 April 2018
                : 8
                : 1
                : 010419
                Affiliations
                [1 ]Nigerian Urban Reproductive Health Initiative, Abuja, Nigeria
                [2 ]Johns Hopkins Centre for Communication Programs, Baltimore, Maryland, USA
                [3 ]Centre for Global Health Research and the World Health Organization Collaborating Centre for Population Health Research and Training, Usher Institute, University of Edinburgh, Scontland, UK
                [4 ]Computer and Information Sciences, Covenant University, Ota, Ogun State, Nigeria
                [5 ]Department of Health Science, California State University, Fullerton, California, USA
                [6 ]Department of Urology, Morriston Hospital, Abertawe Bro Morgannwg University Health Board, Swansea, UK
                [7 ]Health Initiative Department, National Jewish Hospital, Denver, Colorado, USA
                [8 ]Department of Health Studies, Texas Woman's University, Denton, Texas, USA
                [9 ]Department of Computer Engineering, Atilim University, Turkey
                [10 ]Department of Community Medicine, Aminu Kano Teaching Hospital, Bayero University, Kano, Nigeria
                [11 ]School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Fylde Road, Preston, UK
                [12 ]Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
                [13 ]Palliative and Advanced Illness Research (PAIR) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
                Author notes
                Correspondence to:
Dr. Davies Adeloye
Nigerian Urban Reproductive Health Initiative
No 10 Aderemi Adesoji Street
Abuja
Nigeria
 bummyadeloy@ 123456gmail.com
                Article
                jogh-08-010419
                10.7189/jogh.08.010419
                5903682
                2a081676-ccb4-43e1-88bf-7aa5efe2d9a7
                Copyright © 2018 by the Journal of Global Health. All rights reserved.

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                Page count
                Figures: 4, Tables: 4, Equations: 0, References: 80, Pages: 21
                Categories
                Articles

                Public health
                Public health

                Comments

                Comment on this article